PATENT CLAIM ANALYSIS

Application Number: 16183593
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "489000"]

Abstract:
The present invention provides ophthalmic formulations containing cyclosporine, methods for preparing the formulation, and methods for using the formulation.

Claim (Index 35):
A method of treating an ophthalmic condition in a subject in need thereof, comprising administering to the eye of a subject with an ophthalmic condition a nanoemulsion formulation of a cyclosporine comprising:\n (a) a cyclosporine selected from the group consisting of cyclosporines A, B, C, D, and G; (b) at least one solvent; (c) at least one oil; (d) at least one surfactant; and (e) an aqueous phase; wherein the cyclosporine is present (i) in a particulate form in suspension in the nanoemulsion, (ii) dissolved in the aqueous phase, and (iii) dissolved in globules of the at least one oil.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 98.0
- Lexical Diversity: 1.29412
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12007902', '14623150', '15142709', '15546205', '11363379']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7305898019769157
- 35 USC 102 Novelty (BERT): 0.5559887467693867
- Combined Prediction Score: 0.7131296964561629
- Mean Citation Score: 248.336942
- Max Citation Score: 435.34525
- Similarity Product: 358.4720324956924

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test